These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31724285)

  • 1. Long noncoding RNA 91H overexpression contributes to the growth and metastasis of HCC by epigenetically positively regulating IGF2 expression.
    Yi T; Wang T; Shi Y; Peng X; Tang S; Zhong L; Chen Y; Li Y; He K; Wang M; Zhao H; Li Q
    Liver Int; 2020 Feb; 40(2):456-467. PubMed ID: 31724285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
    Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
    Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
    Gao T; He B; Pan Y; Xu Y; Li R; Deng Q; Sun H; Wang S
    Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA 91H regulates IGF2 expression by interacting with IGF2BP2 and promotes tumorigenesis in colorectal cancer.
    Gao T; Liu X; He B; Pan Y; Wang S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):664-671. PubMed ID: 32070145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alterations contribute to promoter activity of imprinting gene IGF2.
    Zheng QF; Xu B; Wang HM; Ding LH; Liu JY; Zhu LY; Qiu H; Zhang L; Ni GY; Ye J; Gao SB; Jin GH
    Biochim Biophys Acta Gene Regul Mech; 2018 Feb; 1861(2):117-124. PubMed ID: 29413895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
    Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X
    Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H19 antisense RNA can up-regulate Igf2 transcription by activation of a novel promoter in mouse myoblasts.
    Tran VG; Court F; Duputié A; Antoine E; Aptel N; Milligan L; Carbonell F; Lelay-Taha MN; Piette J; Weber M; Montarras D; Pinset C; Dandolo L; Forné T; Cathala G
    PLoS One; 2012; 7(5):e37923. PubMed ID: 22662250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma.
    Kim KS; Lee YI
    Cancer Lett; 1997 Nov; 119(2):143-8. PubMed ID: 9570364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential promoter usage for insulin-like growth factor-II gene in Chinese hepatocellular carcinoma with hepatitis B virus infection.
    Tang SH; Yang DH; Huang W; Zhou M; Zhou HK; Lu XH; Ye G
    Cancer Detect Prev; 2006; 30(2):192-203. PubMed ID: 16697535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway.
    Huang Z; Su G; Bi X; Zhang L; Xu Z; Wang G
    Bioengineered; 2021 Dec; 12(1):6952-6966. PubMed ID: 34516353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inhibition of miR-663b by long non-coding RNA HOTAIR promotes pancreatic cancer cell proliferation via up-regulation of insulin-like growth factor 2.
    Cai H; An Y; Chen X; Sun D; Chen T; Peng Y; Zhu F; Jiang Y; He X
    Oncotarget; 2016 Dec; 7(52):86857-86870. PubMed ID: 27895308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.
    Amit D; Hochberg A
    J Transl Med; 2010 Dec; 8():134. PubMed ID: 21162716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.
    Yang J; Li Y; Yu Z; Zhou Y; Tu J; Lou J; Wang Y
    Mol Med Rep; 2020 Jun; 21(6):2395-2404. PubMed ID: 32323783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H19 Promotes HCC Bone Metastasis Through Reducing Osteoprotegerin Expression in a Protein Phosphatase 1 Catalytic Subunit Alpha/p38 Mitogen-Activated Protein Kinase-Dependent Manner and Sponging microRNA 200b-3p.
    Huang Z; Chu L; Liang J; Tan X; Wang Y; Wen J; Chen J; Wu Y; Liu S; Liao J; Hou R; Ding Z; Zhang Z; Liang H; Song S; Yang C; Zhang J; Guo T; Chen X; Zhang B
    Hepatology; 2021 Jul; 74(1):214-232. PubMed ID: 33615520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
    Li X; Nong Z; Ekström C; Larsson E; Nordlinder H; Hofmann WJ; Trautwein C; Odenthal M; Dienes HP; Ekström TJ; Schirmacher P
    Cancer Res; 1997 May; 57(10):2048-54. PubMed ID: 9158004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes.
    Ramani K; Mavila N; Ko KS; Mato JM; Lu SC
    J Biol Chem; 2016 Nov; 291(46):24148-24159. PubMed ID: 27687727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.